We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+15.92%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$67.5M
AUM Growth
+$6.33M
Cap. Flow
-$3.94M
Cap. Flow %
-5.84%
Top 10 Hldgs %
31.63%
Holding
112
New
35
Increased
20
Reduced
22
Closed
29

Top Buys

Rank Stock Value
1
VYGR icon
Voyager Therapeutics
VYGR
+$1.84M
2
UNP icon
Union Pacific
UNP
+$1.69M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.51M
4
AAPL icon
Apple
AAPL
+$1.4M
5
BIIB icon
Biogen
BIIB
+$1.39M

Top Sells

Rank Stock Value
1
AET
Aetna Inc
AET
+$2.28M
2
AMAT icon
Applied Materials
AMAT
+$1.53M
3
ABBV icon
AbbVie
ABBV
+$1.13M
4
MCK icon
McKesson
MCK
+$1.11M
5
ALDR
Alder Biopharmaceuticals
ALDR
+$1.01M

Sector Composition

Rank Sector Weight
1 Healthcare 41.99%
2 Technology 10.99%
3 Communication Services 6.92%
4 Consumer Discretionary 6.39%
5 Energy 4.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGNX icon
76
Regenxbio
RGNX
$708M
$86K 0.13%
+6,126
New +$67.6K
DMTX
77
DELISTED
Dimension Therapeutics, Inc
DMTX
$79K 0.12%
9,885
-4,876
-33% -$35.3K
AMAT icon
78
CALL
Applied Materials
AMAT
$428B
– –
-40,700
Closed -$976K
AMAT icon
79
Applied Materials
AMAT
$428B
– –
-63,793
Closed -$1.53M
AR icon
80
Antero Resources
AR
$10.7B
– –
-29,620
Closed -$770K
BDX icon
81
Becton Dickinson
BDX
$48.7B
– –
-5,047
Closed -$835K
BMY icon
82
CALL
Bristol-Myers Squibb
BMY
$132B
– –
-32,600
Closed -$2.4M
BMY icon
83
Bristol-Myers Squibb
BMY
$132B
– –
-9,099
Closed -$584K
CBRE icon
84
CBRE Group
CBRE
$42.9B
– –
-29,774
Closed -$788K
HAL icon
85
Halliburton
HAL
$26.6B
– –
-15,080
Closed -$683K
HOLX
86
DELISTED
Hologic
HOLX
– –
-18,827
Closed -$651K
INVA icon
87
Innoviva
INVA
$1.48B
– –
-2,703
Closed -$28K
JAZZ icon
88
CALL
Jazz Pharmaceuticals
JAZZ
$16.7B
– –
-4,100
Closed -$579K
LIVN icon
89
LivaNova
LIVN
$4.2B
– –
-4,993
Closed -$251K
LLY icon
90
PUT
Eli Lilly
LLY
$1.06T
– –
-20,300
Closed -$1.6M
MCK icon
91
McKesson
MCK
$101B
– –
-5,929
Closed -$1.11M
MRK icon
92
PUT
Merck
MRK
$318B
– –
-45,483
Closed -$2.5M
MSFT icon
93
Microsoft
MSFT
$3.71T
– –
-17,341
Closed -$887K
OEF icon
94
PUT
iShares S&P 100 ETF
OEF
$20.6B
– –
-1,900
Closed -$489K
PBYI icon
95
Puma Biotechnology
PBYI
$454M
– –
-22,740
Closed -$677K
QQQ icon
96
CALL
Invesco QQQ Trust
QQQ
$484B
– –
-10,000
Closed -$1.07M
THC icon
97
Tenet Healthcare
THC
$21.1B
– –
-13,136
Closed -$363K
UHS icon
98
Universal Health Services
UHS
$10.5B
– –
-5,105
Closed -$685K
VRTX icon
99
Vertex Pharmaceuticals
VRTX
$126B
– –
-3,425
Closed -$295K
XLB icon
100
CALL
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
– –
-28,600
Closed -$976K
1 2 3
4
5

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2016 Portfolio in Review

As of Q3 2016, Partner Investment Management held 112 positions worth $67.5M, up 10% from $61.1M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Partner Investment Management withdrew a net $3.94M in Q3 2016, closing 29 positions and reducing 22 holdings. Its most notable exit was Aetna Inc, an estimated $2.28M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 41% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Partner Investment Management opened a new position in Union Pacific worth $1.76M.

  • Partner Investment Management's largest Q3 2016 buy was Union Pacific: 18,018 shares worth $1.76M.
  • Partner Investment Management added most to Voyager Therapeutics in Q3 2016, an estimated $1.84M increase.
  • Partner Investment Management's biggest Q3 2016 reduction was AbbVie, cutting an estimated $1.13M.
  • Partner Investment Management fully exited Aetna Inc in Q3 2016, selling an estimated $2.28M.
  • Partner Investment Management's ten largest holdings make up 32% of its $67.5M portfolio in Q3 2016.
  • Partner Investment Management opened 35 new positions and closed 29 in Q3 2016.
  • Partner Investment Management's portfolio value rose 10% quarter-over-quarter to $67.5M.

Based on Partner Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.